CNC

Centene Corp
NYSEHEALTHCAREHEALTHCARE PLANS

Key Statistics

Market Cap
$34.16B
P/E Ratio
—
EPS
$-10.44
Beta
1.13
52W High
$71.21
52W Low
$31.63
50-Day MA
$65.29
200-Day MA
$54.01
Dividend Yield
—
Profit Margin
-2.83%
Forward P/E
11.22
PEG Ratio
0.75

About Centene Corp

Centene Corporation is a large publicly traded company and a multi-line managed care enterprise that serves as a major intermediary for both government-sponsored and privately insured health care programs. It is a healthcare insurer that focuses on managed care for uninsured, underinsured, and low-income individuals.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$180.30B
Gross Profit (TTM)$20.58B
EBITDA$4.61B
Operating Margin3.76%
Return on Equity-20.40%
Return on Assets2.48%
Revenue/Share (TTM)$366.37
Book Value$45.67
Price-to-Book1.36
Price-to-Sales (TTM)0.19
EV/Revenue0.0971
EV/EBITDA3.91
Quarterly Earnings Growth (YoY)18.30%
Quarterly Revenue Growth (YoY)4.60%
Shares Outstanding$494.00M
Float$463.68M
% Insiders0.39%
% Institutions101.74%

Historical Volatility

HV 10-Day
23.23%
HV 20-Day
26.36%
HV 30-Day
32.47%
HV 60-Day
33.29%
HV Rank
6.7%

Volatility is currently contracting

Analyst Ratings

Consensus ($71.78 target)
1
Strong Buy
7
Buy
12
Hold
1
Sell

Latest News

Centene Corporation Demonstrates Commitment to CHOICE Arrangements through Benefit Programs in Indiana, Ohio and Oklahoma

Expansion into Ohio and Oklahoma for plan year 2027 builds on early success offering employees  CHOICE Arrangements in Indiana in 2026 ST. LOUIS, Oct. 16, 2026 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced the expansion of its CHOICE Arrangements benefit program (formerly ICHRA) to employees in Ohio and Oklahoma for plan year 2027.

PRNewsWire10/16/2026Neutral
Centene: The Turnaround Has More Room To Run

Centene Corp. maintains a Buy rating as profitability recovers faster than expected, with Q2 2026 adjusted EPS of $2.51 versus a prior-year loss. CNC raised full-year adjusted EPS guidance to over $4.80, driven by improved Marketplace and Medicare Part D margins, despite a 40% YoY decline in Marketplace membership. Medicaid remains a headwind, with expected 8–9% membership decline in 2026 and regulatory risks from OB3, but management targets margin improvement and breakeven Medicare Advantage in 2027.

Seeking Alpha10/15/2026Positive
Centene to Launch Nationwide Gold Card Program for Qualifying Providers

ST. LOUIS, Oct. 13, 2026 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced it will launch its National Performance-Based Gold Card Program in November 2026. The program, which will initially be available to more than 160,000 qualifying providers nationwide for select outpatient services, is designed to streamline the prior authorization review process while maintaining appropriate clinical and quality standards.

PRNewsWire10/13/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CNC and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 10/17/2026